CS logo
small CS logo
National Institute of Endocrinology "C. I. Parhon"

Bucharest, Romania
Hospital in Bucharest
Bulevardul Aviatorilor 34-36, București

About National Institute of Endocrinology "C. I. Parhon"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at National Institute of Endocrinology "C. I. Parhon"


During the past decade, National Institute of Endocrinology "C. I. Parhon" conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Endocrinology "C. I. Parhon"" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at National Institute of Endocrinology "C. I. Parhon"


According to Clinical.Site data, the most researched conditions in "National Institute of Endocrinology "C. I. Parhon"" are "Acromegaly" (4 trials), "Cortisol Excess" (1 trials), "Cortisol Overproduction" (1 trials), "Cortisol; Hypersecretion" (1 trials) and "Cushing Disease Due to Increased ACTH Secretion" (1 trials). Many other conditions were trialed in "National Institute of Endocrinology "C. I. Parhon"" in a lesser frequency.

Clinical Trials Intervention Types at National Institute of Endocrinology "C. I. Parhon"


Most popular intervention types in "National Institute of Endocrinology "C. I. Parhon"" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Paltusotine" (2 trials), "Placebo" (2 trials), "C2L-OCT-01 PR, 10 or 20 mg" (1 trials), "C2L-OCT-01 PR, 20 mg" (1 trials) and "C2L-OCT-01 PR, 30 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Institute of Endocrinology "C. I. Parhon"


The vast majority of trials in "National Institute of Endocrinology "C. I. Parhon"" are 6 trials for "All" genders.

Clinical Trials Status at National Institute of Endocrinology "C. I. Parhon"


Currently, there are NaN active trials in "National Institute of Endocrinology "C. I. Parhon"". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Institute of Endocrinology "C. I. Parhon", undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in National Institute of Endocrinology "C. I. Parhon", 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".